Author details

Full Name

Jennifer C King

Affiliation

ORCID

Career Start Year

2005

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37237339	Leveraging social media to increase lung cancer screening awareness, knowledge and uptake among high-risk populations (The INSPIRE-Lung Study): study protocol of design and methods of a community-based randomized controlled trial.	BMC Public Health	2023
37579304	Getting ready for prime time: Recommended adaptations of an Empathic Communication Skills training intervention to reduce lung cancer stigma for a national multi-center trial.		2023
37577309	Patient-reported impact of symptoms in lung cancer (PRISM-LC).		2023
37057356	Influences on Lung Cancer Screening Initiation and Retention in Rural Alabama.		2023
34774792	Lung Cancer and Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Identifying Important Knowledge Gaps for Investigation.	J Thorac Oncol	2022
35978334	Study protocol of a multiphase optimization strategy trial (MOST)Â for delivery of smoking cessation treatment in lung cancer screening settings.	Trials	2022
34380632	Testicular Cancer: Biology to Bedside.	Cancer Research	2021
34181954	Knowledge and Practice Patterns Among Pulmonologists for Molecular Biomarker Testing in Advanced Non-small Cell Lung Cancer.	Chest	2021
33011390	A 10-Year Cross-Sectional Analysis of Public, Oncologist, and Patient Attitudes About Lung Cancer and Associated Stigma.	Journal of Thoracic Oncology	2021
33396286	Use of a Cancer Registry to Evaluate Patient-Reported Outcomes of Immune Checkpoint Inhibitors.	Cancers	2020
31671279	Eukaryotic initiation factor 5B (eIF5B) regulates temozolomide-mediated apoptosis in brain tumour stem cells (BTSCs).	Biochemistry and Cell Biology	2020
33020472	Glioma-derived IL-33 orchestrates an inflammatory brain tumor microenvironment that accelerates glioma progression.	Nat Commun	2020
33124087	An examination of two dichotomies: Women with lung cancer and living with lung cancer as a chronic disease.	Respirology	2020
30709747	Updates Regarding Biomarker Testing for Non-Small Cell Lung Cancer: Considerations fromÂ the National Lung Cancer Roundtable.	Journal of Thoracic Oncology	2019
31647499	Improving Molecular Oncology by Making Results Available to Patients.	JAMA Oncology	2019
31998820	Survivor and Caregiver Expectations and Preferences Regarding Lung Cancer Treatment.	International Journal of Particle Therapy	2019
30798776	Survivor guilt: The secret burden of lung cancer survivorship.	Journal of Psychosocial Oncology	2019
31150312	Effectiveness of Lung Cancer Screening Implementation in the Community Setting in the United States.	Journal of Oncology Practice	2019
31442408	Dipeptidase-1 Is an Adhesion Receptor for Neutrophil Recruitment in Lungs and Liver.	Cell	2019
30289107	Geographic Availability of Low-Dose Computed Tomography for Lung Cancer Screening in the United States, 2017.	Preventing chronic disease	2018
27607144	Stigma, self-blame, and satisfaction with care among patients with lung cancer.	J Psychosoc Oncol	2017
27006494	Disulfiram when Combined with Copper Enhances the Therapeutic Effects of Temozolomide for the Treatment of Glioblastoma.	Clin Cancer Res	2016
20177012	The American Society of Clinical Oncology Cancer Foundation Grants Program: a 25-year report and a look toward the future.	Journal of Clinical Oncology	2010
19396167	Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis.	Nat Genet	2009
19029823	E2F3 plays an essential role in cardiac development and function.	Cell Cycle	2008
17177598	Epidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domain.	PLoS Med	2006
16357166	Context-dependent hormone-refractory progression revealed through characterization of a novel murine prostate cancer cell line.	Cancer Res	2005